Tag - takeda

 
 

TAKEDA

Japan Times
BUSINESS / Companies
Jan 22, 2019
Japan drugmaker Takeda mulls sale of $3 billion in emerging-market assets
Takeda Pharmaceutical Co. is considering a sale of some emerging-market drugs as it expands a push to cut debt after buying Shire PLC for $62 billion, according to sources.
Japan Times
BUSINESS / Companies
Jan 9, 2019
Takeda's CEO says it needs to sell assets quickly to cut debt
The sooner, the better.
Japan Times
BUSINESS / Companies / ANALYSIS
Dec 6, 2018
Takeda downgrade looms after shareholders approve Shire deal
Takeda Pharmaceutical Co. shareholders' approval of the $62 billion (about ¥7 trillion) acquisition of Shire PLC is good news for its bosses' ambitions to build a global drug giant — but bad news for its credit ratings.
Japan Times
BUSINESS / Companies
Nov 21, 2018
With EU approval secured, Takeda clears last regulatory hurdle for $62 billion Shire purchase
Takeda Pharmaceutical Co. has won European Union approval for its takeover of Shire PLC, clearing the last major regulatory hurdle for the $62 billion acquisition and paving the way to a shareholder vote.
Japan Times
BUSINESS / Companies
Jul 18, 2018
Takeda bets on China for global growth, seeing the country as 'on a par' with the U.S. and Europe
Takeda Pharmaceutical Co. sees China becoming a "core country" for its global growth strategy, and is optimistic its $62 billion (¥6.94 trillion) acquisition of Shire PLC will win approval by the country's regulators.
Japan Times
BUSINESS / Companies / ANALYSIS
Apr 26, 2018
Shire bid marks Takeda's latest and biggest push for global status
Takeda Pharmaceutical Co. Ltd..'s $64 billion bid for London-listed rare-disease specialist Shire PLC bolsters its credentials as Japan's most outward-facing drugs firm, a mold-breaking image that has been more than a decade in the making.
Japan Times
BUSINESS / Companies
Mar 29, 2018
Takeda shares slide amid $50 billion takeover bid for Shire
Shares of Takeda Pharmaceutical Co. fell the most in nine years after the firm disclosed it is considering a bid for Shire PLC that could approach $50 billion (about ¥5.3 trillion), which would be the Japanese company’s biggest takeover ever.
Japan Times
BUSINESS / Companies
Dec 1, 2016
Takeda drug could be part of functional cure for HIV: study
Dr. Anthony Fauci doesn't get too excited about the results of animal studies, and he doesn't make house calls.
BUSINESS / Companies
Feb 3, 2016
Takeda to evaluate Zika vaccine possibilities
Takeda Pharmaceutical Co., Asia's largest drugmaker, has assembled an internal team to look into how it might contribute to vaccine efforts to combat the Zika virus, the mosquito-borne pathogen that is currently spreading through the Americas.
Japan Times
BUSINESS / Companies / EXECUTIVE DECISIONS
Aug 11, 2014
Takeda Pharmaceutical to stay Japan-based while growing on global basis, new French leader vows
The inauguration in June of Christophe Weber as president of Takeda Pharmaceutical Co. invited opposition from a group of its former executives and members of its founding family, but the Frenchman says Takeda will remain "Japanese-based" under his leadership.

Longform

Mount Fuji is considered one of Japan's most iconic symbols and is a major draw for tourists. It's still a mountain, though, and potential hikers need to properly prepare for any climb.
What it takes to save lives on Mount Fuji